Bausch Health Companies Inc. surprised investors with a significant earnings beat this quarter, showcasing resilience in its business segments.
Recent earnings trend
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.61B
52W high
$11.97
52W low
$6.10
1W change
+52.21%
Beta
0.42
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 27.4% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-27.4% Upside
Current Price
C$9.65
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
93.6%
Annualized
90-Day Vol
63.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$11.54
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.24 | C$7.41 – C$14.15 |
| 60 trading days | C$10.87 | C$6.88 – C$17.16 |
| 90 trading days | C$11.54 | C$6.59 – C$20.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 7 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 3 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-10-28 | — | 1.1700 | — |
| 2026-06-30 | 2026-07-29 | 1.2600 | 1.0100 | +24.8% |
| 2026-03-31 | 2026-04-29 | 0.7800 | 0.6900 | +13.0% |
| 2025-12-31 | 2026-02-18 | 1.1000 | 1.2100 | -9.1% |
| 2025-09-30 | 2025-10-29 | 1.1600 | 1.0600 | +9.4% |
| 2025-06-30 | 2025-07-30 | 0.9100 | 0.9400 | -3.2% |
Advertisement
On July 29, 2026, Bausch Health Companies Inc. (BHC.TO) reported its second-quarter earnings, revealing an adjusted EPS of $1.26, surpassing analysts' expectations by 24.8%. This performance underscores the company's ongoing recovery and growth trajectory.
Investor takeaway: For Canadian investors, Bausch Health's latest earnings indicate a positive shift in its financial health, particularly driven by strong sales in its Salix and Solta Medical segments. However, the stock's bearish analyst consensus suggests cautious optimism moving forward.
Bausch Health's Q2 EPS Surprises by +24.8%
The reported EPS of $1.26 exceeded the estimate of $1.01, marking a 40% year-over-year increase and a surprise of 24.75%.
Bull case
Bausch's strong revenue growth, especially in its Salix segment thanks to Xifaxan, and the positive earnings surprise could signal a turnaround. This might attract more investor interest and improve stock performance.
Bear case
Even with the earnings beat, analysts remain cautious, reflected in a bearish consensus rating. The significant year-to-date stock decline raises concerns about whether this growth can be sustained and if the company can maintain its momentum in a competitive pharmaceutical market.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
